News | June 04, 2026
Novo Nordisk launches Wegovy pill in UAE in first global rollout outside US
The move signals a major expansion in access to next-generation weight-loss therapies
The move signals a major expansion in access to next-generation weight-loss therapies
Marks first international filing for Evofem’s single-dose oral treatment
This registration enables companies to register the products (Orodispersible films and Transdermal systems) in UAE for commercialization
To set up 50 lifestyle modification centres across the UAE in the next 24 months
Exclusive distribution agreement brings Point-Of-Care (POC) haematology diagnostics to new regions in the Middle East
The agreement also had a permanent safeguard mechanism which can be resorted to in a situation of sudden surge in imports.
In 2019, diabetes was the ninth leading cause of death with an estimated 1.5 million deaths directly caused by diabetes, as per WHO
Booster dose is available to all residents aged 18+ and can be applied six months after the second dose of any other vaccine administered in UAE
Veteran healthcare leader to oversee operations across Tamil Nadu and Kerala, driving growth and operational excellence
SFDA nod marks company’s strategic entry into high-value specialty oncology injectables as it targets expanding stem cell transplant and haemato-oncology market in the GCC region
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
